GlassScriptPhysician profile
James Earl Stanton
NPI 1932280724
$5,937.72
in general payments reported to CMS, 2019-2025
24 companies · $327 in 2025
The $327 reported for 2025 was more than what 85% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $900 · 2020: $357 · 2021: $1,074 · 2022: $1,107 · 2023: $1,081 · 2024: $1,092 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,500.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $933.37 | 2019-2023 | Lokelma, Fasenra |
| Pfizer INC. | $655.08 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $615.45 | 2019-2025 | Jardiance, Spiriva Respimat |
| Janssen Pharmaceuticals, INC | $553.15 | 2019-2024 | Xarelto |
| Abbvie INC. | $500.46 | 2021-2025 | Teflaro, Dalvance |
| Glaxosmithkline, LLC. | $333.44 | 2021-2024 | Trelegy Ellipta, Arexvy |
| Merck Sharp & Dohme LLC | $321.37 | 2023-2025 | Zerbaxa, Dificid, Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $311.11 | 2019-2025 | Lifevest |
| Allergan, INC. | $281.50 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $278.86 | 2019-2024 | |
| Daiichi Sankyo INC. | $277.12 | 2019-2023 | Injectafer |
| Otsuka America Pharmaceutical, INC. | $232.39 | 2019 | |
| Novo Nordisk INC | $165.43 | 2020-2025 | Ozempic, Rybelsus |
| Paratek Pharmaceuticals, INC. | $124.34 | 2022-2025 | Nuzyra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $114.67 | 2019-2024 | Xifaxan |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $71.28 | 2021-2023 | |
| Kestra Medical Technology Services, INC. | $37.58 | 2023 | Assure Wcd |
| Abbott Laboratories | $22.26 | 2022 | |
| Medtronic, INC. | $21.00 | 2021 | |
| Inari Medical, INC. | $20.99 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sunovion Pharmaceuticals INC. | $18.52 | 2019 | |
| Philips North America LLC | $17.41 | 2022 | |
| Amgen INC. | $16.12 | 2022 | |
| Vifor Pharma, INC. | $14.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Stanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.